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Abstract
Background: Colombia was the second most affected country during the American Zika virus (ZIKV) epidemic, with
over 109,000 reported cases. Despite the scale of the outbreak, limited genomic sequence data were available from
Colombia. We sought to sequence additional samples and use genomic epidemiology to describe ZIKV dynamics in
Colombia.
Methods: We sequenced ZIKV genomes directly from clinical diagnostic specimens and infected Aedes aegypti
samples selected to cover the temporal and geographic breadth of the Colombian outbreak. We performed
phylogeographic analysis of these genomes, along with other publicly-available ZIKV genomes from the Americas, to
estimate the frequency and timing of ZIKV introductions to Colombia.
Results: We attempted PCR amplification on 184 samples; 19 samples amplified sufficiently to perform sequencing.
Of these, 8 samples yielded sequences with at least 50% coverage. Our phylogeographic reconstruction indicates two
separate introductions of ZIKV to Colombia, one of which was previously unrecognized. We find that ZIKV was first
introduced to Colombia in February 2015 (95%CI: Jan 2015 – Apr 2015), corresponding to 5 to 8 months of cryptic
ZIKV transmission prior to confirmation in September 2015. Despite the presence of multiple introductions, we find
that the majority of Colombian ZIKV diversity descends from a single introduction. We find evidence for movement of
ZIKV from Colombia into bordering countries, including Peru, Ecuador, Panama, and Venezuela.
Conclusions: Similarly to genomic epidemiological studies of ZIKV dynamics in other countries, we find that ZIKV
circulated cryptically in Colombia. More accurately dating when ZIKV was circulating refines our definition of the
population at risk. Additionally, our finding that the majority of ZIKV transmission within Colombia was attributable to
transmission between individuals, rather than repeated travel-related importations, indicates that improved detection
and control might have succeeded in limiting the scale of the outbreak within Colombia.
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Background
In recent years, countries across the Americas have expe-
rienced the emergence and endemic circulation of various
mosquito-borne viruses, making this a critical area for
public health surveillance and epidemiologic research.
Zika virus (ZIKV) caused a particularly widespread
epidemic, with over 800,000 suspected or confirmed
cases reported [1]. Given estimated seroprevalence rates
between 36% and 76% [2–5], the true number of ZIKV
infections in the Americas is likely much higher. With
neither a vaccine nor ZIKV-specific treatments avail-
able, understanding the epidemiology of ZIKV is our
primary tool for controlling disease spread [6]. However,
because many infections are asymptomatic [2], the
analysis of surveillance data alone yields inaccurate esti-
mates of when ZIKV arrived in a country [7, 8]. In such
cases, introduction timing and transmission dynamics
post-introduction are better inferred from genomic
epidemiological studies, which use joint analysis of viral
genome sequences and epidemiologic case data. Indeed,
such studies have defined our understanding of when
ZIKV arrived in Brazil [7], described general patterns of
spread from Brazil into other countries in the Americas
[7, 9, 10], and been used to investigate the extent of
endemic transmission occurring post-introduction
[8]. Genomic epidemiological studies of the spread of
ZIKV in the Americas have aided our understanding
of the epidemic [7–19], but generally, ZIKV pathogen
sequencing has remained a challenge for the public health
community [20].
Colombia has a population of approximately 48 million
people. In addition, Colombia has Aedes aegypti and
Ae. albopictus mosquitoes, which are commonly found
at elevations below 2000m above sea level [21]. Public
health surveillance for arboviral diseases, along with
other notifiable conditions, is performed by the Insti-
tuto Nacional de Salud de Colombia (INS) [21]. While
suspected cases from other municipalities were reported
earlier [22], the INS first confirmed ZIKV circulation
in mid-September 2015, in the Turbaco municipality
on the Caribbean coast. ZIKV spread throughout the
country, appearing in areas infested with Ae. aegypti that
experience endemic dengue transmission and previous
circulation of chikungunya virus [23]. Over the entire
epidemic Colombia reported 109,265 cases of Zika virus
disease [24], making it the second most ZIKV-affected
country in the Americas after Brazil. The extent of the
epidemic led the INS to start active surveillance for con-
genital Zika syndrome [25] as well as other neurological
syndromes associated with ZIKV infection [26]. While
the INS determined that epidemic ZIKV transmission
ended in July 2016, they continue to perform surveillance
for endemic transmission.
Despite numerous reported cases, only 12 whole ZIKV
genomes from Colombian clinical samples were pub-
licly available. These sequences included 1 sample from
Barranquilla, Atlántico department, 4 samples from
Santander department, and 7 sequences for which depart-
mental or municipal information was unspecified. We
sequenced an additional 8 samples from ZIKV-positive
human clinical and Ae. aegypti specimens, sampled from
previously unrepresented Colombian departments. We
describe here the first detailed phylogeographic analysis of
Colombian ZIKV to estimate when, and how frequently,
ZIKV was introduced into Colombia.
Methods
INS sample selection and processing
The INS National Virological Reference Laboratory col-
lected diagnostic specimens from over 32,000 suspected
ZIKV cases over the course of the epidemic. Of these,
roughly 800 serum specimens were positive for ZIKV by
real time RT-PCR (rRT-PCR) and had cycle threshold
(Ct) values less than 30. From this set we selected 176
serum specimens that were ZIKV-positive, but negative
for dengue and chikungunya viruses, as per results from
the Trioplex rRT-PCR assay [27]. Specimens were selected
such that each Colombian department was represented
over the entire time period in which specimens were
submitted. We extracted RNA using the MagNA Pure
96 system (Roche Molecular Diagnostics, Pleasanton,
CA, USA) according to manufacturer’s instructions. An
extraction negative was used for each plate; positive con-
trols were eschewed given the risk of cross-contaminating
low titer clinical samples [20]. We attempted reverse tran-
scription and PCR-amplification of ZIKV using the two-
step multiplex PCR protocol developed by Quick and
colleagues on all 176 extracted samples [20]. Briefly,
cDNA was generated using random hexamer priming and
the Protoscript II First Strand cDNA Synthesis Kit (New
England Biolabs, Ipswich,MA, USA).We amplified cDNA
using the Zika Asian V1 ZIKV-specific primer scheme
[20], which amplifies 400bp long overlapping amplicons
across the ZIKV genome, over 35 cycles of PCR. Amplicons
were purified using 1× AMPure XP beads (Beckman
Coulter, Brea, CA, USA) and quantified using with the
Qubit dsDNA High Sensitivity assay on the Qubit 3.0
instrument (Life Technologies, Carlsbad, CA, USA). Due
to long storage periods and variable storage temperature,
the vast majority of samples were too degraded to amplify.
Of the 176 processed samples, only 15 amplified suffi-
ciently to perform sequencing.
UR sample selection and processing
Universidad del Rosario (UR) collected and performed
diagnostic testing on 23 human clinical samples from dif-
ferent geographic regions, and 38 Ae. aegypti samples
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from the Cordoba department of Colombia. RNA was
extracted using the RNeasy kit (Qiagen, Hilden, Ger-
many) and a single TaqMan assay (Applied Biosystems,
Foster City, CA, USA) directed to ZIKV was employed
[28] to confirm ZIKV presence. Approximately 60% of
samples (14 clinical samples and 23 Ae. aegypti sam-
ples) were found to be ZIKV-positive by rRT-PCR. From
these, we attempted amplification on 8 samples with suf-
ficiently high viral copy numbers that they were likely
to amplify. Amplification, purification, and quantification
of ZIKV amplicons from UR samples were performed
as described above. Of the eight samples that we per-
formed PCR on, four samples amplified sufficiently to
conduct sequencing; three samples were from human
clinical specimens and one was from an Ae. aegypti
sample.
Sequencing protocol
We sequenced amplicons from 4 UR and 15 INS
samples using the Oxford Nanopore MinION (Oxford
Nanopore Technologies, Oxford, UK) according to the
protocol described in Quick et al. [20]. Amplicons
were barcoded using the Native Barcoding Kit EXP-
NBD103 (Oxford Nanopore Technologies, Oxford, UK)
and pooled in equimolar fashion. Sequencing libraries
were prepared using the 1D Genomic DNA Sequenc-
ing kit SQK-LSK108 (Oxford Nanopore Technologies,
Oxford, UK). We used AMPure XP beads (Beckman
Coulter, Brea, CA, USA) for all purification steps per-
formed as part of library preparation. Prepared libraries
were sequenced on R9.4 flowcells (Oxford Nanopore
Technologies, Oxford, UK) at the INS in Bogotá and
at the Fred Hutchinson Cancer Research Center in
Seattle.
Bioinformatic processing
Raw signal level data from the MinION were basecalled
using Albacore version 2.0.2 (Oxford Nanopore Tech-
nologies, Oxford, UK) and demultiplexed using Porechop
version 0.2.3_seqan2.1.1 (github.com/rrwick/Porechop).
Primer binding sites were trimmed from reads using
custom scripts, and trimmed reads were mapped to
Zika reference strain H/PF/2013 (GenBank Accession
KJ776791) using BWA v0.7.17 [29]. We used Nanopolish
version 0.9.0 (github.com/jts/nanopolish) to determine
single nucleotide variants from the event-level data, and
used custom scripts to extract consensus genomes given
the variant calls and the reference sequence. Coverage
depth of at least 20x was required to call a SNP; sites
with insufficient coverage were masked with N, denoting
that the exact nucleotide at that site is unknown. After
bioinformatic assembly, 8 samples produced sufficiently
complete genomes to be informative for phylogenetic
analysis.
Dataset curation
All publicly available Asian lineage ZIKV genomes and
their associated metadata were downloaded from ViPR
[30] and NCBI GenBank. The full download contained
both published and unpublished sequences; we sought
written permission from submitting authors to include
sequences that had not previously been published on. Any
sequences for which we did not receive approval were
removed. Additionally, we excluded sequences from the
analysis if any of the following conditions were met: the
sequence had ambiguous base calls at half or more sites
in the alignment, the sequence was from a cultured clone
for which a sequence from the original isolate was avail-
able, the sequence was sampled from countries outside
the Americas or Oceania, or geographical sampling infor-
mation was unknown. Finally, we also excluded viruses
whose estimated clock rate was more than 4 times the
interquartile distance of clock rates across all sequences
in the analysis. Sequences that deviate this greatly from
the average evolutionary rate either have far too many
or too few mutations than expected given the date they
were sampled. This deviation usually occurs if the given
sampling date is incorrect, or if the sequence has been
affected by contamination, lab adaptation, or sequenc-
ing error. After curation, the final dataset consisted of
360 sequences; 352 publicly available ZIKV full genomes
from the the Americas (including Colombia) and Ocea-
nia, and the 8 Colombian genomes from the present
study.
Phylogeographic analysis
Data were cleaned and canonicalized using Nextstrain
Fauna (github.com/nextstrain/fauna), a databasing
tool that enforces a schema for organizing sequence data
and sample metadata, thereby creating datasets com-
patible with the Nextstrain Augur analytic pipeline
(github.com/nextstrain/augur) and theNextstrain Auspice
visualization platform (github.com/nextstrain/auspice).
A full description of the Nextstrain pipelines can
be found in Hadfield et al. [31]. Briefly, Nextstrain
Augur performs a multiple sequence alignment with
MAFFT [32], which is then trimmed to the reference
sequence. A maximum likelihood phylogeny is inferred
using IQ-TREE [33]. Augur then uses TreeTime [34]
to estimate a molecular clock; rates inferred by Tree-
Time are comparable to BEAST [34], a program that
infers temporally-resolved phylogenies in a Bayesian
framework [35]. Given the inferred molecular clock,
TreeTime then creates a temporally-resolved phy-
logeny, infers sequence states at internal nodes, and
estimates the geographic migration history across the
tree. These data are exported as JSON files that can
be interactively visualized on the web using Nextstrain
Auspice.
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Rarefaction analysis
We generated a series of datasets in which ZIKV genomes
from either Colombia or Mexico were subsampled. For
each value from 1 to n, where n is the total number of
available sequences for the country of interest, we gener-
ated 30 subsampled datasets in which n sequences were
randomly sampled without replacement. Each subsam-
pled set was then combined with all ZIKV genomes from
other countries included in the main phylogeographic
analysis described above, and the phylogeographic infer-
ence was rerun. For the Colombian rarefaction analysis,
we have n = 20 high quality whole genomes, so we
inferred 20×30 = 600 phylogeographically labelled trees.
For the Mexican rarefaction analysis, we have n = 51 high
quality whole genomes in total, and inferred 51×30 = 1530
phylogeographically labelled trees. For each labelled tree,
we used custom scripts to traverse the resulting phylogeny
and count the number of ZIKV introductions into the
country of interest. We then plotted the inferred intro-
duction count as a function of the number of sequences
sampled.
Results
Sequencing and sampling characteristics of reported ZIKV
genomes
In total, we attempted to amplify ZIKV nucleic acid from
184 samples collected by the Instituto Nacional de Salud
de Colombia (INS) and Universidad del Rosario (UR).
Given the low viral titers associated with most ZIKV
infections, as well as long storage times, most samples
did not amplify well. We attempted sequencing on 19
samples that amplified sufficiently to generate sequenc-
ing libraries (Table 1). Sequencing efforts yielded eight
ZIKV sequences with at least 50% coverage across the
genome with unambiguous base calls (Table 1). Seven of
these viruses came from humans; one virus came from
an Ae. aegypti pool. Three sequences came from samples
collected from infected individuals in Cali, department
of Valle del Cauca, two sequences came from Montería,
department of Córdoba, and one sequence each came
from Ibagué, department of Tolima, Belén de Umbría,
department of Risaralda, and Pitalito, department of Huila
(Fig. 1). Colombian viruses are sampled across the period
of peak ZIKV incidence in Colombia (Fig. 2).
General patterns of ZIKV transmission in the Americas
We conducted a maximum likelihood phylogeographic
analysis of 360 Asian lineage ZIKV genomes; 18 sequences
are sampled from Oceania, and 342 sequences are sam-
pled from the Americas.We estimate the ZIKV evolution-
ary rate to be 8.65 × 10−4 substitutions per site per year,
in agreement with other estimates of the ZIKV molecu-
lar clock [7, 10, 11, 36] made with BEAST [35], a Bayesian
method for estimating rates of evolution and inferring
Table 1 Metadata and percent of genome that was able to be called unambiguously for 19 samples that amplified sufficiently to
attempt sequencing
Strain Name Collection Date Ct Value Municipality Department Coverage
COL/FH01/2016 2016-02-24 Positive Montería Córdoba 4.1%
COL/FH02/2016 2016-02-29 Positive Montería Córdoba 94.3%
COL/FH03/2016 2016-03-09 Positive Ibagué Tolima 94.3%
Aedes_aegypti/COL/FH04/2016 2016-01-29 Positive Montería Córdoba 96.1%
COL/FH05/2016 2016-07-27 16 Belén de Umbría Risaralda 96.1%
COL/FH06/2016 2016-05-03 22 Barranquilla Atlántico 0.0%
COL/FH07/2016 2016-05-16 23 Pitalito Huila 55.7%
COL/FH08/2016 2016-08-25 Positive Cali Valle del Cauca 0.0%
COL/FH09/2016 2016-11-02 Positive Cali Valle del Cauca 94.3%
COL/FH10/2015 2015-12-16 24.72 Girardot Cundinamarca 0.0%
COL/FH11/2016 2016-02-10 Positive Taminango Nariño 0.0%
COL/FH12/2016 2016-03-22 24.46 Villagarzón Putumayo 0.0%
COL/FH13/2016 2016-04-01 27.56 San Andrés San Andrés 10.4%
COL/FH14/2016 2016-05-26 21 Villavicencio Meta 35.5%
COL/FH15/2016 2016-05-12 23.85 Imported Case Imported Case 21.0%
COL/FH16/2016 2016-06-22 24 Cali Valle del Cauca 81.8%
COL/FH17/2016 2016-06-27 Positive Barranquilla Atlántico 0.0%
COL/FH18/2016 2016-08-08 Positive Barranquilla Atlántico 0.0%
COL/FH19/2016 2016-08-30 Positive Cali Valle del Cauca 81.8%
Not all samples had annotated Ct values; rather, in some cases, samples were only specified to be positive or negative for ZIKV
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Fig. 1 Geographic sampling locations for the eight Colombian genomes with at least 50% unambiguous genome coverage. Colombia is
highlighted with departmental boundaries shown. Three genomes come from Cali and and two genomes come from Montería. All other cities have
one genome each. The land-sea mask, coastline, lake, river and political boundary data are extracted from datasets provided by Generic Mapping
Tools (GMT) licensed under GNU General Public License
temporally-resolved phylogenies. Consistent with other
studies, we find that ZIKV moved from Oceania to the
Americas, and that the American epidemic descends
from a single introduction into Brazil (Fig. 3a). We esti-
mate that this introduction occurred in late September
2013 (95%CI: August 2013 – March 2014), inline with
Faria et al′s [11] initial estimate of introduction to Brazil
between May and December 2013, and updated esti-
mate of introduction between October 2013 and April
2014 [7]. We also confirm findings from previous studies
Fig. 2 Numbers of recorded cases weekly from the beginning of the Colombian epidemic to the end of 2017. Sampling dates for 20 Colombian
genomes, including the eight sequenced as part of this study, are indicated by circles above the epidemiologic curve. One sample lacked
information about sampling date, and sampling date was inferred. This sample is indicated as an unfilled circle
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Fig. 3 Phylogeographic analysis of 360 publicly available ZIKV genomes. A Temporally-resolved maximum likelihood phylogeny of 360 ZIKV
genomes from the Americas and Oceania. Tip colors indicate known country of sampling and branch colors indicate geographic migration history
inferred under the phylogeographic model. The full tree can be explored interactively at nextstrain.org/community/blab/zika-colombia. B The same
phylogeny as in panel A, but filtered to highlight only genomes sampled from Colombia. The phylogeny shows two separate introductions of ZIKV
into Colombia, resulting in varying degrees of sampled onward transmission
[7, 10] that ZIKV circulated in Brazil for approximately
one year before moving into other South American
countries to the north, including Colombia, Venezuela,
Suriname, and French Guiana. Movement of ZIKV into
Central America occurs around late-2014 while move-
ment into the Caribbean occurs slightly later, around
mid-2015 (Fig. 3a).
Multiple introductions of ZIKV to Colombia
We infer patterns of ZIKV introduction and spread in
Colombia from the phylogenetic placement of 20 Colom-
bian sequences. Previously, 12 of these sequences were
publicly available. We add an additional 8 Colombian
sequences sampled over a broad geographic and tempo-
ral range. Colombian ZIKV sequences clustered into two
distinct clades (Fig. 3b). Both clades are descended from
viruses inferred to be from Brazil (Fig. 3a). Viruses imme-
diately ancestral to both Colombian clades are estimated
by the phylogeographic model to have 100% model sup-
port for a Brazilian origin. However, lack of genomic sam-
pling frommany ZIKV-affected countries in the Americas
may limit our ability to infer direct introduction from
Brazil or transmission through unsampled countries prior
to arrival in Colombia.
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Clade 1 is comprised of 28 viruses, 17 of which are
from Colombia, and is characterized by nucleotide muta-
tions T738C, C858T, G864T, C3442T, A3894G, C5991T,
C9279T, and A10147G. This clade contains all previ-
ously reported Colombian genomes, as well as five of the
genomes generated during this study (Figs. 3 and 4). The
phylogeographic model places the root of this clade in
Colombia with 99% model support. The most parsimo-
nious reading is that this clade of viruses resulted from a
single introduction event from Brazil into Colombia.
Clade 2 contains 5 viruses, 3 of which are from
Colombia (Figs. 3 and 5). All three were sequenced dur-
ing this study, and thus this clade was not previously
recognized in Colombia. This clade is characterized by
mutations T1858C, A3780G, G4971T, C5532T, G5751A,
A6873G, T8553C, and C10098T. The phylogeographic
model places the root of this clade in Colombia with 98%
model support and also suggests a Brazil to Colombia
transmission route that is likely, but not certainly, direct.
Two additional genomes with less that 50% genomic cov-
erage also group within these clades; COL/FH14/2016
within clade 1 and COL/FH15/2016 within clade 2 (data
not shown).
To examine how our estimate of two introductions to
Colombia might be affected by the number of sequences
available, we conducted rarefaction analyses. Under the
assumption that sequenced viruses are sampled at ran-
dom, these curves show how much genomic sampling
is required to fully sample the circulating viral diversity.
Figure 6 shows the number of introductions to Colombia
or Mexico inferred under the phylogeographic model as a
function of the number of sequences sampled from that
country. For ZIKV in Mexico, we see that the rarefaction
curve begins to flatten once roughly 25 to 30 Mexican
viruses have been sampled (Fig. 6). In contrast, for Colom-
bia we do not observe further ZIKV introductions once we
have sampled around 4 genomes (Fig. 6). Thus, while there
are only 20 ZIKV whole genomes available from Colom-
bia, we think it is unlikely that we would observe more
ZIKV introductions given more sequence data.
Transmission within Colombia
We estimate that clade 1 was introduced to Colombia
around late February of 2015 (95% CI: January 2015 to
April 2015) (Figs. 3b and 4), and that clade 2 was intro-
duced in mid September of 2015 (95% CI: July 2015 to
November 2015) (Figs. 3b and 5). Our estimate of clade
1 introduction timing supports between five and eight
months of cryptic ZIKV transmission within Colombia
prior to initial case detection in September 2015, a find-
ing that is consistent with other genomic epidemiological
studies of ZIKV [7, 8, 10].
Genomes were sampled from 7 of 32 departments
within Colombia (Fig. 7a). Four genomes were sampled
from Santander, three viruses were sampled from Valle
del Cauca, and two viruses came fromCórdoba. One virus
each was sampled from Risaralda, Tolima, Huila, and
Atlántico departments respectively (Fig. 7b and c). Seven
of the publicly-available Colombian ZIKV genomes lacked
department-level information (Fig. 7b). Given that many
ZIKV-affected departments within Colombia have only
minimal genomic sampling, or lack it all together, we have
refrained from using phylogeographic methods to recon-
struct the direction of transmission between Colombian
Fig. 4 Phylogeny of 28 clade 1 viruses. The inferred geographic migration history indicates movement from Brazil into Colombia, with subsequent
migration into other countries in South America, Central America, and the Caribbean. The estimate of introduction timing and the 95% confidence
interval are given for the most basal node of the clade
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Fig. 5 Phylogeny of 5 clade 2 viruses. The inferred geographic migration history indicates movement from Brazil into Colombia, with subsequent
migration into Ecuador as evidenced by the nesting of Ecuadorian genomes EcEs062_16 and EcEs089_16. The estimate of introduction timing and
the 95% confidence interval are given for the most basal node of the clade
departments. However, we do note some signals of geo-
graphic influence on transmission within the phylogenies.
For example, two closely related clade 1 viruses
(COL/2016/SU_1810A and COL/2016/SU_2724A) were
both sampled from Santander, and may be linked cases.
Transmission from Colombia to other countries
We find evidence for onward transmission fromColombia
into other countries in the Americas. Clade 1 showsmove-
ment of viruses into countries that share a border with
Colombia, namely Panama, Venezuela, and Peru, as well
as into the Dominican Republic and Martinique (Fig. 4).
Clade 2 indicates movement of Colombian ZIKV into
neighboring Ecuador (Fig. 5). Transmission from Colom-
bia into bordering countries seems reasonable, and these
patterns agree with previously documented trends of
ZIKV expansion in the Americas [7, 9, 10], but provide
more detail due to the greater amounts of sequence data
now available. For instance, analysis by Metsky et al.
[10] also supports movement of ZIKV from Colombia to
Martinique and the Dominican Republic. However, with-
out sequence data from Panama, Peru, or Venezuela, they
were unable to capture spread from Colombia into these
countries.
Discussion
Despite the scale of the Colombian epidemic, publicly
available sequence data were limited, and no detailed
genomic epidemiological analysis of ZIKV dynamics had
been performed.We sought to improve genomic sampling
for Colombia, and to perform a detailed genomic analysis
of the Colombian epidemic. Only 12 Colombian genomes
were available prior to this study. To these data we added
8 new sequences sampled broadly across Colombia, and
Fig. 6 Rarefaction curves for Mexican ZIKV and Colombian ZIKV. For both Mexico and Colombia, the number of introductions into the country is
plotted as a function of the number of genomes sampled from that country, where genomes are subsampled from available sequences. The
colored circles show introduction counts for all of the phylogeographically labelled trees; they are sized according to the frequency with which a
specific number of introductions was observed for a given level of subsampling. The black line shows the mean number of introductions observed
for a given level of subsampling
The Author(s) BMC Infectious Diseases          (2019) 19:963 Page 9 of 11
Fig. 7 Department-level sampling information for 20 viruses sequenced from Colombia. A Colombian departments from which ZIKV was sampled
are highlighted. These departments included Santander, Valle del Cauca, Córdoba. Risaralda, Tolima, Huila, and Atlántico departments. Seven
genomes lack public information about which department they were sampled from. The land-sea mask, coastline, lake, river and political boundary
data are extracted from datasets provided by Generic Mapping Tools (GMT) licensed under GNU General Public License. B Phylogeny of clade 1
viruses, colored by department of sampling. Viruses not sampled from Colombia are indicated with white tips, and Colombian viruses lacking
department information are colored dark grey. C Phylogeny of clade 2 viruses, colored by department of sampling. Viruses not sampled from
Colombia are indicated with white tips
performed a phylogeographic analysis of American ZIKV.
We describe general transmission patterns across the
Americas and present estimates of ZIKV introduction
timing and frequency specific to Colombia. We find evi-
dence of at least two introductions of ZIKV to Colombia,
yet remarkably the majority of Colombian viruses cluster
within a single clade, indicating that a single introduc-
tion event caused themajority of ZIKV cases in Colombia.
Under the assumption that viruses sequenced from
Colombia are random samples of Colombian ZIKV cases,
we find that Colombian ZIKV diversity is well represented
by 20 Colombian genomes. It is therefore unlikely that fur-
ther genomic sampling would reveal more introductions
of ZIKV into Colombia. ZIKV dispersal out of Colombia
appears widespread, with movement to bordering coun-
tries (Panama, Venezuela, Ecuador, and Peru) as well as
more distal countries in the Caribbean.
While it may be tempting to read the inferred phylogeo-
graphic migration history as a complete record of trans-
mission between countries, we caution against doing this
for analyses of ZIKV. In contrast to other large outbreaks,
such as the Ebola epidemic in West Africa, genomic sam-
pling of the American ZIKV epidemic is sparse. Many
ZIKV-affected countries have minimal genomic sampling;
others have none at all. Thus while the phylogeographic
model will correctly infer the geographic location of inter-
nal nodes given the dataset at hand, adding sequences
from previously unsampled countries may alter migra-
tion histories such that apparent direct transmission from
country A to country C instead becomes transmission
from country A to country B to country C.
Consistent with other studies, our estimates of when
introductions to Colombia occurred support cryptic
ZIKV transmission prior to initial case confirmation. Per-
haps more surprisingly, our estimate of the age of clade
1 indicates that ZIKV likely spread to Colombia even
before official confirmation of ZIKV circulation in Brazil
[37]. These findings underscore the utility of genomic
epidemiology to date introduction events and describe
transmission patterns that are difficult to detect using
traditional surveillance methods, thereby providing more
accurate definitions of the population at risk and a bet-
ter understanding of how importation and within-country
transmission shape epidemics.
Conclusions
We found evidence for two separate introductions of
ZIKV to Colombia, one of which occurred five to eight
months prior to the official confirmation of ZIKV in
Colombia. Refining our estimates of when ZIKV cir-
culated in Colombia improves our definition of when
individuals were at risk for ZIKV infection. Accurately
defining this exposure period increases the ability
of population-level observational studies to properly
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measure associations between ZIKV infection and out-
comes of interest. In addition, we found that the majority
of ZIKV diversity in Colombia descends from one of these
two introductions, and rarefaction analyses suggest that
we would not identify more introductions with greater
genomic sampling. Taken together, these findings suggest
that most cases of ZIKV infection were attributable to
ZIKV transmission within Colombia after a single intro-
duction event, and that cases of ZIKV infection acquired
in other countries and brought back to Colombia were
rare. As the majority of Colombian ZIKV infections were
locally-acquired, infection prevention and control mea-
sures targeting local spread might have limited the scale
of the outbreak within Colombia.
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